共 50 条
- [41] PD-1 inhibitors combined with chemotherapy versus chemotherapy alone: efficacy and prognostic analysis in recurrent metastatic nasopharyngeal carcinoma AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (06): : 2622 - 2632
- [43] The Role of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E804 - E804
- [44] Short- and Long-Term Outcomes of Neoadjuvant Stereotactic Body Radiation Therapy vs. Neoadjuvant Conventional Radiation Therapy in Patients with Pancreatic Cancer INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E198 - E198
- [45] Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1408 - 1414
- [46] PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1073 - 1074
- [48] Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S326 - S327